Startup profile for Humanos: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

Humanos funding, valuation and investors

Lisbon startup building live risk scores and risk passports for AI agents; raised $3.2 million seed.

Keep track of Humanos

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Seed

$3.2M · September 28, 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$3.2M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

seed · Lisbon, Portugal

Investors in latest funding

Lead: Anthemis

Other: Springbank , Critical Ventures , Start Ventures

Sources: latest funding Last verified: 2026-09-30

Overview

Humanos builds continuously updated risk scores for AI agents based on identity, permissions, behavior and activity. On September 28, 2026 Dealroom reported a $3.2 million seed led by Anthemis, with Springbank, Critical Ventures and Start Ventures participating.

Why Humanos is interesting

Fits the emerging AI-agent governance layer and complements VCT's Reco, Rig, Outerlimit, Kontext and HelmGuard coverage.

Key facts

  • Sep 28, 2026: $3.2M seed led by Anthemis
  • Product: live risk scores and risk passports for AI agents

Funding history (newest first)

Seed

2026-09-28 $3.2M
  • Anthemis (lead)
  • Springbank (participant)
  • Critical Ventures (participant)
  • Start Ventures (participant)

Source: https://dealroom.co/news/157114-humanos-raises-3-2m-to-score-the-risk-of-ai-agents-in-real-time/

Market / IPO context

Editorial / static context — not a live quote.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.